ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Editas Medicine is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Editas Medicine stays above 3.2, but if it comes below 3.2, then a intra day sell could be more profitable.
If you take a sell trade below 3.2, then use 3.2 as stoploss and 2.8 as target. However if you take a buy trade in Editas Medicine, then use 3.2 as stoploss and 3.7 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

ETMarkets AIF Talk| Performing credit emerges as core portfolio allocation for investors: Amit Dharod India’s private credit market is emerging as a key part of alternative investments, supported by structural changes in lending and rising demand for stable returns. Once a niche, performing credit is becoming a core allocation, driven by a funding gap in m - NEWS as on 2026-04-16 indiatimes.com

U.S. Physical Therapy Closes 0 Mln Credit Facility (RTTNews) - U.S. Physical Therapy, Inc. (USPH), a chain of outpatient physical therapy clinics, Wednesday announced that it is closing a 0 million, five-year credit facility that includes a 5 million term loan and a 5 million revolver with a matur - NEWS as on 2026-04-15 nasdaq.com

Credit penetration among women rise 5-fold to Rs 76 lakh crore between 2017 and 2025 Women borrowers have seen a significant five-fold increase in credit access, reaching Rs 76 lakh crore by 2025. This represents 26% of all credit. Business loans for women have grown substantially, indicating a shift towards income-generating activities. D - NEWS as on 2026-04-13 indiatimes.com

Banks’ exposure to carbon-intensive sectors raises long-term credit risk, costs: IIM Lucknow study Banks financing carbon-heavy industries face growing credit risks. Research from IIM Lucknow shows this exposure leads to higher monitoring and recovery costs over time. Financial institutions must align lending with a low-carbon economy. Stronger capital - NEWS as on 2026-04-12 indiatimes.com

Global Market: Japan sees no major risk from private credit, flags global concerns Japan's Finance Minister stated that private credit is not a significant domestic risk, as companies still rely on traditional bank financing. However, authorities are closely monitoring the rapidly growing global market and Japanese banks' increasing cros - NEWS as on 2026-04-10 indiatimes.com

Global Market | Private credit faces growing strains as redemptions rise and AI risks loom The private credit market, a decade-old alternative to bank lending, is showing early signs of stress with rising investor redemptions and moderating returns. Concerns are mounting over opacity and the impact of AI-driven disruption on heavily financed tec - NEWS as on 2026-04-06 indiatimes.com

Banks' credit growth to moderate in FY27; NPAs to inch up: Crisil Ratings Banks' credit growth is projected to slightly slow to 13% in FY27, with a potential 0.20% rise in bad loans to 2.5% by March 2027, according to Crisil. MSME loans exposed to West Asia, along with micro-loans and unsecured advances, are key concerns. Othe - NEWS as on 2026-04-01 indiatimes.com

Real-time checks to improve discipline in credit cycle Lenders will now report to credit bureaus weekly, a shift from fortnightly, enhancing real-time borrower risk assessment. This move is expected to improve underwriting standards by enabling continuous monitoring and reassessment of borrower risk throughout - NEWS as on 2026-03-30 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 3.25
  • 12Day Average: 2.92
  • 20Day Average: 2.68
  • 50Day Average: 2.3
  • 100Day Average: 2.27
  • 150Day Average: 2.59
  • 200Day Average: 2.62

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.98, 2.71, 0.2
Indicator MACD is in positive zone

Indicator ADX (14)

12.5, 37.5, 29.17
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 62
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Thu Apr 2026 3.36 3.22 to 3.40 -0.3% 0.79 times
15 Wed Apr 2026 3.37 3.33 to 3.58 -0.59% 0.96 times
14 Tue Apr 2026 3.39 3.23 to 3.55 5.94% 1.42 times
13 Mon Apr 2026 3.20 2.89 to 3.26 8.84% 1.46 times
10 Fri Apr 2026 2.94 2.79 to 2.95 1.73% 0.97 times
09 Thu Apr 2026 2.89 2.71 to 2.92 4.71% 0.82 times
08 Wed Apr 2026 2.76 2.68 to 2.94 0.73% 0.65 times
07 Tue Apr 2026 2.74 2.56 to 2.76 1.48% 0.94 times
06 Mon Apr 2026 2.70 2.57 to 2.82 1.12% 0.97 times
02 Thu Apr 2026 2.67 2.53 to 2.69 2.69% 0.69 times
01 Wed Apr 2026 2.60 2.50 to 2.75 5.26% 1.12 times
31 Tue Mar 2026 2.47 2.25 to 2.52 10.76% 1.15 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top